The EMA has released key guidelines on the responsible use of large language models (LLMs) in regulatory science. Discover how AI tools like GPT can streamline tasks while addressing privacy and accuracy challenges, and learn about the EMA’s approach to safe and ethical implementation.
Join us when biopharma industry and AI experts will explore real-world applications, emerging trends, and key challenges in ensuring AI accuracy and trustworthiness.
Explore key takeaways from the PHUSE US Connect 2024 conference, highlighting the future of clinical trials, the importance of data integrity, and the role of AI/ML methodologies. Discover how Cyntegrity's vision for QbD and integrated RBQM is shaping the industry.
We proudly present our virtual dialogue on Responsible AI in Clinical Trials this November 15 & 16, uniting industry and academic experts for groundbreaking discussions and insights.
MyRBQM Portal has made its debut on the Azure Marketplace. This milestone allows biopharmaceutical companies to streamline and unify their approach to risk management by using the secure and reliable Azure cloud platform.
On the wings of the Butterfly Challenge, our CEO Artem Andrianov and Junior Data Scientist Ting-Yu Ho shared their scientific knowledge with 10th graders helping them acquire real-world vision.
